Index.php

Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical firms, which includes the makers of Xarelto, have a duty to make sure that their drugs are reasonably secure for use - and failure to perform so may possibly be grounds for compensation. Our lawyers are operating hard to acquire those hurt by the drug the compensation they may be entitled to.

Even though bleeding is really a common complication linked with anticoagulants, it has been alleged that Xarelto is a lot more harmful than traditional blood thinners because no antidote exists to reverse its blood-thinning effects. This indicates that, in the event of an emergency, patients might be at risk for irreversible bleeding difficulties, including life-threatening internal and gastrointestinal hemorrhaging.

In case you or perhaps a loved one particular suffered a serious bleeding occasion after taking Xarelto, you might have legal recourse. For far more data, get in touch with us these days to possess your case reviewed, free of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for past and future medical bills, lost wages, discomfort and suffering and, in instances of death, funeral costs. Additionally, they are seeking punitive damages, which are normally awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Being Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding within the occasion of an emergency. Plaintiffs within the lawsuits allege significant and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a secure anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a xarelto law firm user inside the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.

Visit this page for far more data on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.